Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal Carcinoma.

Trial Profile

Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal Carcinoma.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 26 May 2017

At a glance

  • Drugs Cetuximab; Cisplatin; Fluorouracil
  • Indications Nasopharyngeal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 01 May 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 09 Nov 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top